22-04 Case Studies in Women's Health: Diagnosis, Treatment Decisions and Outcomes for Women with Fibroids
(NPWH Activity Number 22-04)
Shelagh Larson DNP, APRN, WHNP, NCMP
Target Audience Women's Health Nurse Practitioners (WHNPs) WHNP students, Certified Nurse Midwives (CNMs), and other nurse practitioners and advanced practice clinicians.
Approval CE Approval Period: Now through January 31, 2023
Post-tests must be completed during the approval period with a passing score of 70% or higher to earn CE. No refunds will be issued if the activity is not completed within the approval period.
This activity has been approved for 0.5 continuing education contact hours including 0.25 hours of pharmacology content.
- Initiate discussions with patients concerning symptoms that stem from fibroids, including their effect on quality of life, fertility, and comorbidities.
- Evaluate and diagnose patients with symptoms suggestive of leiomyomas.
- Select a patient-centered approach to medical treatment that meet patient goals for relief from symptoms while minimizing side effects and reducing the need for other interventions.
- Review and modify, as needed, current treatments, based on patient satisfaction for symptom relief.
Accreditation StatementThis activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH) and has been approved for 0.5 contact hour of CE credit, including 0.25 hours of pharmacology content.
Faculty Disclosures Shelagh Larson DNP, APRN, WHNP, NCMP has the following disclosures: serves on the Menopause Panel for Pfizer, the Brexafemme Advisory Board for Synexis and is a Nexplanon trainer for Merck.
Successful Completion Requires participants to:
- Read the objectives, disclosures, and disclaimers.
- Watch the activity and review the handout.
- Complete the post-test with a score of 70% or higher.
- Complete the session evaluation.
- Print your CE certificate.
- Go to your profile to view all earned certificates.
Commercial Support This activity is supported by an educational grant from the Myovant Sciences-Pfizer Inc Alliance